SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-23-000010
Filing Date
2023-01-03
Accepted
2023-01-03 07:05:27
Documents
15
Period of Report
2023-01-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2328943.htm   iXBRL 8-K 35138
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 27265
7 image00001.jpg GRAPHIC 11852
  Complete submission text file 0001178913-23-000010.txt   269411

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cmmb-20230103.xsd EX-101.SCH 4644
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmmb-20230103_def.xml EX-101.DEF 18314
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmmb-20230103_lab.xml EX-101.LAB 28540
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmmb-20230103_pre.xml EX-101.PRE 20556
9 EXTRACTED XBRL INSTANCE DOCUMENT zk2328943_htm.xml XML 6617
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 23500176
SIC: 2834 Pharmaceutical Preparations